David Lubkowicz

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Vincent M. Isabella, Binh Ha, Mary Joan Castillo et al. · Nature Biotechnology · 2018 · 548 citations

Biosynthesis, Engineering, Biotechnology +6

Reprogramming Probiotic <i>Lactobacillus reuteri</i> as a Biosensor for <i>Staphylococcus aureus</i> Derived AIP-I Detection

David Lubkowicz, Chun Loong Ho, In Young Hwang et al. · ACS Synthetic Biology · 2018 · 86 citations

Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip

Mark Nelson, Mark R. Charbonneau, Heidi G. Coia et al. · Nature Communications · 2021 · 70 citations · Full text

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and <i>in silico</i> simulations of enteric hyperoxaluria

David Lubkowicz, Nicholas G. Horvath, Michael J. James et al. · Molecular Systems Biology · 2022 · 42 citations · Full text

Urology, Engineering, Preclinical Models +7

Transplantability of a circadian clock to a noncircadian organism

Anna H. Chen, David Lubkowicz, Vivian Yeong et al. · Science Advances · 2015 · 36 citations · Full text